Literature DB >> 8199786

Future imperfect: the long-term outcome of depression.

P G Surtees1, C Barkley.   

Abstract

During 1976, 80 patients with a primary depressive illness were selected from a consecutive series of referrals to the Royal Edinburgh Hospital for a short-term follow-up study. This paper concerns the 12-year longitudinal assessment of the survivors. During the follow-up, mortality risk for the sample was almost doubled. Of the series, 35% had experienced a recurrence within 2 years of the initial interview, and just over 60% within the entire study time of 12 years. The risk of recurrence was enhanced for those aged over 45 years at index, for those with a history of depressive disorder and for those who had not engaged in parasuicidal behaviour during the index episode. The observed effect of previous episodes was largely accounted for by age. The chance of recurrence was not affected by whether the treatment of the index episode included ECT, or by whether diagnosis was 'endogenous' or 'neurotic'. Application of the Lee-Murray outcome criteria showed that about one-third of the Edinburgh series experienced a very poor outcome. Results are presented concerning the prediction of long-term outcome as represented by the Depression Outcome Scale (DOS), a measure specially constructed for this study.

Entities:  

Mesh:

Year:  1994        PMID: 8199786     DOI: 10.1192/bjp.164.3.327

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  9 in total

1.  Which depressive symptoms remain after response to cognitive therapy of depression and predict relapse and recurrence?

Authors:  Daniel J Taylor; Heather M Walters; Jeffrey R Vittengl; Steven Krebaum; Robin B Jarrett
Journal:  J Affect Disord       Date:  2009-09-05       Impact factor: 4.839

2.  Prospective studies of cothymia (mixed anxiety-depression): how do they inform clinical practice?

Authors:  P Tyrer; H Seivewright; S Simmonds; T Johnson
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2001       Impact factor: 5.270

Review 3.  Sertraline. A pharmacoeconomic evaluation of its use in depression.

Authors:  R Davis; M I Wilde
Journal:  Pharmacoeconomics       Date:  1996-10       Impact factor: 4.981

Review 4.  Pharmacotherapy to sustain the fully remitted state.

Authors:  Sidney Kennedy; Roger McIntyre; Angelo Fallu; Raymond Lam
Journal:  J Psychiatry Neurosci       Date:  2002-07       Impact factor: 6.186

5.  Course and outcome of acute non-organic psychotic states in India.

Authors:  V K Varma; S Malhotra; E S Yoo; R C Jiloha; M T Finnerty; E Susser
Journal:  Psychiatr Q       Date:  1996

6.  The impact of classification on psychopharmacology and biological psychiatry.

Authors:  H M van Praag
Journal:  Dialogues Clin Neurosci       Date:  1999-12       Impact factor: 5.986

7.  Stability of lithium treatment in bipolar disorder - long-term follow-up of 346 patients.

Authors:  Anne Berghöfer; Martin Alda; Mazda Adli; Christopher Baethge; Michael Bauer; Tom Bschor; Paul Grof; Bruno Müller-Oerlinghausen; Janusz K Rybakowski; Alexandra Suwalska; Andrea Pfennig
Journal:  Int J Bipolar Disord       Date:  2013-07-31

8.  Childhood neglect predicts the course of major depression in a tertiary care sample: a follow-up study.

Authors:  Sabrina Paterniti; Irit Sterner; Christine Caldwell; Jean-Claude Bisserbe
Journal:  BMC Psychiatry       Date:  2017-03-28       Impact factor: 3.630

Review 9.  Psychosocial determinants of recovery in depression.

Authors:  Giovanni A Fava; Dalila Visani
Journal:  Dialogues Clin Neurosci       Date:  2008       Impact factor: 5.986

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.